Alpha-7 Nicotinic Receptors in Nervous System Disorders: From Function to Therapeutic Perspectives

E-ISSN： 1875-6166|17|2|100-108

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.17, Iss.2, 2017-07, pp. : 100-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nicotinic Receptors as Therapeutic Targets for Drug Addictive Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 5, 2013-08 ,pp. : 633-640

Bentham Science Publishers

Access to resources Recommend Favorite

Alpha7 Neuronal Nicotinic Receptor: A Pluripotent Target for Diseases of the Central Nervous System

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 5, 2014-06 ,pp. : 836-845

Bentham Science Publishers

Access to resources Recommend Favorite

New Insight into the Therapeutic Role of 5-HT1A Receptors in Central Nervous System Disorders

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 10, Iss. 2, 2010-06 ,pp. : 148-157

Bentham Science Publishers

Access to resources Recommend Favorite

The Recent Development of 7 Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2134-2151

Bentham Science Publishers

Access to resources Recommend Favorite

Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia

By Wallace Tanya L. Bertrand Daniel

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 2, 2013-02 ,pp. : 139-155

Informa Healthcare

Access to resources Recommend Favorite